Intravenous Immunoglobulin Treatment in Autoimmune Neurological Disorders—Effects on Quality of Life
- 30 April 2005
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 66 (4) , 417-421
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profilePharmacology & Therapeutics, 2004
- Intravenous Immunoglobulin in Autoimmune Neuromuscular DiseasesJAMA, 2004
- Immune mediated neuropathiesJournal of Neurology, 2004
- Guillain-Barr?? SyndromeDrugs, 2004
- Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravisBrain, 2003
- The pathogenesis of CIDPNeurology, 2003
- Multifocal motor neuropathyJournal of Neuroimmunology, 2001
- Multifocal Motor NeuropathySeminars in Neurology, 1998
- Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United StatesClinical Immunology and Immunopathology, 1997
- Myasthenia GravisNew England Journal of Medicine, 1994